Cereno Scientific, Webcast, Update on CS1 Phase 2 clinical study, 2022
February 25th 2022 15:00 (Europe/Stockholm)Language:
English
Speaker:
Sten R. Sörensen CEO, Dr Björn Dahlöf CMO, Dr Raymond Benza Prof. of Medicine & Director for Cardiovascular Diseases at Wexner Medical Center, Ohio State University, Dr Philip Adamson Divisional VP and CMO Abbott Heart Failure Division
Sector:
Health care - Pharmaceuticals & Biotechnology
Listing:
First North
Activity:
Webcast